Article
Effects of aging on clinical outcomes in patients receiving genotype-guided P2Y12 inhibitor selection after percutaneous coronary intervention.
Pharmacotherapy - 1 Dec 2021
Wood Brian, Lee Craig R, Mulrenin Ian R, Gower Megan N, Rossi Joseph S, Weck Karen E, Stouffer George A
Abstract excerpt
STUDY OBJECTIVE: To compare the clinical effectiveness of genotype-guided P2Y12 inhibitor selection following PCI in older patients (≥70 years) and younger patients (<70 years). DESIGN AND SETTING: Single-center, retrospective, cohort study. Risk of major adverse cardiovascular or cerebrovascular events (MACCE), defined as stent thrombosis, ischemic stroke, transient ischemic attack, non-fatal acute coronary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
